Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Infectious Disease Reports
Published in: Current Infectious Disease Reports 3/2017

01-03-2017 | Respiratory Infections (F Arnold, Section Editor)

Enterovirus D68-Associated Community-Acquired Pneumonia in the Pediatric Age Group

Authors: Samantha Bosis, Susanna Esposito

Published in: Current Infectious Disease Reports | Issue 3/2017

Login to get access

Abstract

Purpose of Review

This review summarizes the current knowledge regarding the role of Enterovirus D68 (EV-D68) in community-acquired pneumonia (CAP) in children.

Recent Findings

EV-D68 is an emergent viral pathogen. Since its first isolation in 1962 in California in four children suffering from CAP and bronchiolitis, EV-D68 has been rarely detected from respiratory specimens. However, recently, EV-D68 infection has raised concerns in the international community because of outbreaks in 2014 in the USA and the increased number of children with EV-D68-associated severe respiratory illnesses, including pneumonia, that have been reported in many other countries around the world.

Summary

EV-D68 causes severe and life-threatening respiratory diseases in the pediatric population, particularly in children with underlying conditions such as prematurity or chronic diseases. Since no specific treatment or vaccinations are available for EV-D68 infections, greater surveillance as well as the use of sensitive and rapid diagnostic methods are essential to prevent and manage new outbreaks.
Literature
1.
• Lugo D, Krogstad P. Enteroviruses in the early 21st century: new manifestation and challenges. Curr Opin Pediatr. 2016;28:107–13. An interesting review on clinical findings associated with Enteroviruses.CrossRefPubMedPubMedCentral
2.
Khan F. Enterovirus D68 acute respiratory illness and the 2014 outbreak. Emerg Med Clin North Am. 2015;33:e19–32.CrossRefPubMed
3.
•• Principi N, Esposito S. Enterovirus D68: an emerging cause of infection. Expert Rev Respir Med. 2015;6:711–9. A comprehensive overview on Enterovirus D68.CrossRef
4.
Schieble JH, Fox VL, Lennette EH. A probable new human picornavirus associated with respiratory disease. Am J Epidemiol. 1967;85:297–310.CrossRefPubMed
5.
Oermann CM, Schuster JE, Conners GP, Newland JG, Selvarangan R, Jackson MA. Enterovirus D68: a focused review and clinical highlights from the 2014 United States outbreak. Ann Am Thorac Soc. 2015;12:775–81.CrossRefPubMed
6.
Imamura T, Oshitani H. Global reemergence of enterovirus D68 as an important pathogen for acute respiratory infections. Rev Med Virol. 2015;25:102–14.CrossRefPubMed
7.
Midgley CM, Jackson MA, Selvaragan R, Turabelidze G, Obringer E, Johnoson D, et al. Severe respiratory illness associated with enterovirus D68—Missouri and Illinois, 2014. MMWR. 2014;63:798–9.PubMed
8.
Piralla A, Girello A, Grignani M, Gonzalo-Margüello M, Marchi A, Marseglia G, et al. Phylogenetic characterization of enterovirus 68 strains in patients with respiratory syndromes in Italy. J Med Virol. 2014;86:1590–3.CrossRefPubMed
9.
Maijer A, Benschop KS, Donker GA, van der Avoort HG. Continued seasonal circulation of enterovirus D68 in the Netherlands, 2011–2014. Eur Surveill. 2014;19:1–6.
10.
Furuse Y, Chaimongkol N, Okamoto M, Imamura T, Saito M, Tamaki R, et al. Molecular epidemiology of entrovirus D68 from 2013 to 2014 in Philippines. J Clin Microbiol. 2015;53:1015–8.CrossRefPubMedPubMedCentral
11.
Vongpunsaward S, Prachayagprecha S, Chnsaenroj J, Haagmans BL, Smits SL, Poovorawan Y. Genome sequence of enterovirus D68 and clinical disease, Thailand. Emerg Infect Dis. 2015;21:384.CrossRef
12.
Wylie K, Wylie TN, Overdahl A, Buller RS, Herter BN, Magrini V, et al. Genome sequence of enterovirus D68 from St Louis, Missuri, USA. Emerg Infect Dis. 2015;21:184–6.CrossRefPubMedPubMedCentral
13.
14.
Reiche J, Böttcher S, Diedrich S, Buchholz U, Buda S, Haas W, et al. Low-level circulation of enterovirus D68-associated acute respiratory infections, Germany, 2014. Emerg Infect Dis. 2015;21:837–41.CrossRefPubMedPubMedCentral
15.
Torres J, Farfan MJ, Izquierdo G, Piemonte P, Henriquez J, O’Rayan ML. Enterovirus D68 infection, Chile, spring 2014. Emerg Infect Dis. 2015;21:728–9.CrossRefPubMedPubMedCentral
16.
Midgley SE, Christianensen CB, Poulsen MW, Hansen CH, Fisher TK. Emergence of enterovirus D68 in Denmark, June 2014 to February 2015. Eur Surveill. 2015;20:1–6.CrossRef
17.
Gimferrer L, Campins M, Codina MG, Esperalba J, Martin M, Fuentes F, et al. First enterovirus D68 (EV-D68) cases detected in hospitalized patients in a tertiary care university hospital in Spain, October 2014. Enferm Infect Microbiol Clin. 2015;33(9):585–9.CrossRef
18.
Poelmann R, Schölvinck EH, Borger R, Niesters HGM, Van Leer-Buter C. The emergence of enterovirus D68 in a Dutch University Medical Centre and the necessity for routinely screening for respiratory viruses. J Med Virol. 2015;62:1–5.
19.
Drews SJ, Simmonds K, Usman H, Yee K, Fathima S, Tipples G, et al. Characterization of enterovirus activity, including that of enterovirus D68, in pediatric patients in Alberta, Canada in 2014. J Clin Microbiol. 2015;53:1042–5.CrossRefPubMedPubMedCentral
20.
• Esposito S, Zampiero A, Ruggiero L, Madini B, Niesters H, Principi N. Enterovirus D68-associated community-acquired pneumonia in children living in Milan, Italy. J Clin Virol. 2015;68:94–6. Interesting case series on EV-D68 associated CAP.CrossRefPubMed
21.
Imamura T, Fuji N, Suzuki A, Tamaki R, Saito M, Aniceto R, et al. Enterovirus 68 among children with severe acute respiratory infection, the Philippines. Emerg Infect Dis. 2011;17:1430–35.PubMedPubMedCentral
22.
Abedi GR, Watson JT, Pham H, Nix WA, Oberste MS, Gerber SI. enterovirus and human paraechovirus surveillance: United States. MMWR Morb Mortal Wkly Rep. 2015;64:940–3.CrossRefPubMed
23.
Ikeda T, Mizuta K, Abiko C, Aoki Y, Itagaki T, Katsushima F, et al. Acute respiratory infections due to enterovirus 68 in Yamagata, Japan between 2005 and 2010. Microbiol Immunol. 2012;56:139–43.CrossRefPubMed
24.
Meijer A, van der Sanden S, Snijders BE, Jaramillo-Gutierrez G, Bont L, van der Ent CK, et al. Emergence and epidemic occurrence of enterovirus 68 respiratory infections in the Netherlands in 2010. Virology. 2012;423:49–57.CrossRefPubMed
25.
• Greninger A, Naccarche SN, Messacar K, Clayton A, Yu G, Somasekar S, et al. A novel outbreak enterovirus D68 strain associated with acute flaccid myelitis cases in the USA (2012–14): a retrospective cohort study. Lancet Infect Dis. 2015;15:1–12. A comprehensive retrospective description of acute flaccid myelitis cases associated with EV-D68.CrossRef
26.
Pfeiffer HC, Bragstad K, Skram MK, Dahl H, Knudsen PK, Chawla MS, et al. Two cases of acute severe flaccid myelitis associated with enterovirus D68 infection in children, Norway, autumn 2014. Eur Surveill. 2015;20:1–5.CrossRef
27.
Lang M, Mirand A, Savy N, Henquell C, Maridet S, Perignon R, et al. Acute flaccid paralysis following enterovirus D68 associated pneumonia, France, 2014. Eur Surveill. 2014;1:1–5.
28.
•• Massacar K, Schreiner TL, Maloney JA, Wallace A, Ludke J, Oberste MS, et al. A cluster of acute flaccid paralysis and cranial nerve dysfunction temporally associated with an outbreak of enterovirus D68 in children in Colorado, USA. Lancet. 2015;385:1662–71. A complete description of neurologic involvement during EV-D68 outbreak.CrossRef
29.
Murray JS, Mirch MC, Amin PM. Enterovirus D68: what pediatric healthcare professionals need to know. J Spec Pediatr Nurs. 2015;20:131–5.CrossRefPubMed
30.
Tokarz R, Firth C, Madhi SA, Howie SRC, Wu W, Sall AA, et al. Worldwide emergence of multiple clades of enterovirus 68. J Gen Virol. 2012;3:1952–8.CrossRef
31.
• Du J, Zheng B, Zheng W, Li P, Kang J, Hou J, et al. Analysis of enterovirus 68 strains from the 2014 North America outbreak reveals a new clade indicating viral evolution. PLoS One. 2015;10, e0144208. An updated description documenting EV-D68 evolution.CrossRefPubMedPubMedCentral
32.
Peci A, Winter AL, Warshwsky B, Booth TF, Eshaghi A, Li A, et al. Epidemiology of enterovirus D68 in Ontario. PLoS One. 2015;23, e0142841.CrossRef
33.
Bragstad K, Jakobsen K, Rojahn AE, Skram MK, Vainio K, Holberg-Petersen M, et al. High frequency of enterovirus D68 in children hospitalized with respiratory illness in Norway, autumn 2014. Influenza Other Respir Viruses. 2015;9:59–63.CrossRefPubMed
34.
Mertz D, Alawfi A, Pernica JM, Rutherford C, Luinstra K, Smieja M. Clinical severity of pediatric respiratory illness with enterovirus D68 compared with rhinovirus or other enterovirus genotypes. CMAJ. 2015;187:1279–84.CrossRefPubMedPubMedCentral
35.
• Schuster JE, Miller JO, Selvarangan R, Weddle G, Thompson MT, Hassan F, et al. Severe enterovirus 68 respiratory illness in children requiring intensive care management. J Clin Virol. 2015;70:77–82. A detailed description of EV-D68 associated respiratory complications.CrossRefPubMed
Metadata
Title
Enterovirus D68-Associated Community-Acquired Pneumonia in the Pediatric Age Group
Authors
Samantha Bosis
Susanna Esposito
Publication date
01-03-2017
Publisher
Springer US
Published in
Current Infectious Disease Reports / Issue 3/2017
Print ISSN: 1523-3847
Electronic ISSN: 1534-3146
DOI
https://doi.org/10.1007/s11908-017-0567-8

Other articles of this Issue 3/2017

Current Infectious Disease Reports 3/2017 Go to the issue

Cardiovascular Infections (B Hoen, Section Editor)

Indications of Surgery in Infective Endocarditis

Respiratory Infections (F Arnold, Section Editor)

Risk Factors for Drug-Resistant Cap in Immunocompetent Patients

Tropical, Travel and Emerging Infections (L Chen, Section Editor)

Live Attenuated Yellow Fever 17D Vaccine: A Legacy Vaccine Still Controlling Outbreaks In Modern Day

Central Nervous System Infections (K Bloch, Section Editor)

Herpes Simplex Encephalitis: an Update
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits